世界の人工呼吸器関連肺炎（VAP）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ventilator Associated Pneumonia (VAP) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5898 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、人工呼吸器関連肺炎（VAP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（予防、理学療法、免疫療法）、用途別市場規模（病院、ASC、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・人工呼吸器関連肺炎（VAP）の市場動向 ・企業の競争状況、市場シェア ・人工呼吸器関連肺炎（VAP）の種類別市場規模（予防、理学療法、免疫療法） ・人工呼吸器関連肺炎（VAP）の用途別市場規模（病院、ASC、診断センター） ・人工呼吸器関連肺炎（VAP）の北米市場規模2016-2027（アメリカ、カナダ） ・人工呼吸器関連肺炎（VAP）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・人工呼吸器関連肺炎（VAP）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・人工呼吸器関連肺炎（VAP）の中南米市場規模2016-2027（メキシコ、ブラジル） ・人工呼吸器関連肺炎（VAP）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Philips Respironics、Hoffrichter、Johnson Controls、Teleflex、Weinmann、ResMed、SYSMED、Fisher & Paykel） ・結論

Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Market
The global Ventilator Associated Pneumonia (VAP) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ventilator Associated Pneumonia (VAP) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ventilator Associated Pneumonia (VAP) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ventilator Associated Pneumonia (VAP) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ventilator Associated Pneumonia (VAP) market.

Global Ventilator Associated Pneumonia (VAP) Scope and Market Size
Ventilator Associated Pneumonia (VAP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ventilator Associated Pneumonia (VAP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prevention
Physiotherapy
Immunity Therapy

Segment by Application
Hospitals
ASCs
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Philips Respironics
Hoffrichter
Johnson Controls
Teleflex
Weinmann
ResMed
SYSMED
Fisher & Paykel

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prevention
1.2.3 Physiotherapy
1.2.4 Immunity Therapy
1.3 Market by Application
1.3.1 Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ventilator Associated Pneumonia (VAP) Market Perspective (2016-2027)
2.2 Ventilator Associated Pneumonia (VAP) Growth Trends by Regions
2.2.1 Ventilator Associated Pneumonia (VAP) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ventilator Associated Pneumonia (VAP) Historic Market Share by Regions (2016-2021)
2.2.3 Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2022-2027)
2.3 Ventilator Associated Pneumonia (VAP) Industry Dynamic
2.3.1 Ventilator Associated Pneumonia (VAP) Market Trends
2.3.2 Ventilator Associated Pneumonia (VAP) Market Drivers
2.3.3 Ventilator Associated Pneumonia (VAP) Market Challenges
2.3.4 Ventilator Associated Pneumonia (VAP) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Revenue
3.1.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Revenue (2016-2021)
3.1.2 Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Players (2016-2021)
3.2 Global Ventilator Associated Pneumonia (VAP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ventilator Associated Pneumonia (VAP) Revenue
3.4 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio
3.4.1 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ventilator Associated Pneumonia (VAP) Revenue in 2020
3.5 Ventilator Associated Pneumonia (VAP) Key Players Head office and Area Served
3.6 Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service
3.7 Date of Enter into Ventilator Associated Pneumonia (VAP) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ventilator Associated Pneumonia (VAP) Breakdown Data by Type
4.1 Global Ventilator Associated Pneumonia (VAP) Historic Market Size by Type (2016-2021)
4.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Type (2022-2027)

5 Ventilator Associated Pneumonia (VAP) Breakdown Data by Application
5.1 Global Ventilator Associated Pneumonia (VAP) Historic Market Size by Application (2016-2021)
5.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ventilator Associated Pneumonia (VAP) Market Size (2016-2027)
6.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Type
6.2.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021)
6.2.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027)
6.2.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027)
6.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Application
6.3.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021)
6.3.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027)
6.3.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027)
6.4 North America Ventilator Associated Pneumonia (VAP) Market Size by Country
6.4.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021)
6.4.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ventilator Associated Pneumonia (VAP) Market Size (2016-2027)
7.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type
7.2.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021)
7.2.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027)
7.2.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027)
7.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application
7.3.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021)
7.3.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027)
7.3.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027)
7.4 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country
7.4.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021)
7.4.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size (2016-2027)
8.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type
8.2.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027)
8.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application
8.3.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027)
8.4 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region
8.4.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size (2016-2027)
9.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type
9.2.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021)
9.2.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027)
9.2.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027)
9.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application
9.3.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021)
9.3.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027)
9.3.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027)
9.4 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country
9.4.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021)
9.4.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size (2016-2027)
10.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type
10.2.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027)
10.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application
10.3.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027)
10.4 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country
10.4.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Philips Respironics
11.1.1 Philips Respironics Company Details
11.1.2 Philips Respironics Business Overview
11.1.3 Philips Respironics Ventilator Associated Pneumonia (VAP) Introduction
11.1.4 Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.1.5 Philips Respironics Recent Development
11.2 Hoffrichter
11.2.1 Hoffrichter Company Details
11.2.2 Hoffrichter Business Overview
11.2.3 Hoffrichter Ventilator Associated Pneumonia (VAP) Introduction
11.2.4 Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.2.5 Hoffrichter Recent Development
11.3 Johnson Controls
11.3.1 Johnson Controls Company Details
11.3.2 Johnson Controls Business Overview
11.3.3 Johnson Controls Ventilator Associated Pneumonia (VAP) Introduction
11.3.4 Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.3.5 Johnson Controls Recent Development
11.4 Teleflex
11.4.1 Teleflex Company Details
11.4.2 Teleflex Business Overview
11.4.3 Teleflex Ventilator Associated Pneumonia (VAP) Introduction
11.4.4 Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.4.5 Teleflex Recent Development
11.5 Weinmann
11.5.1 Weinmann Company Details
11.5.2 Weinmann Business Overview
11.5.3 Weinmann Ventilator Associated Pneumonia (VAP) Introduction
11.5.4 Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.5.5 Weinmann Recent Development
11.6 ResMed
11.6.1 ResMed Company Details
11.6.2 ResMed Business Overview
11.6.3 ResMed Ventilator Associated Pneumonia (VAP) Introduction
11.6.4 ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.6.5 ResMed Recent Development
11.7 SYSMED
11.7.1 SYSMED Company Details
11.7.2 SYSMED Business Overview
11.7.3 SYSMED Ventilator Associated Pneumonia (VAP) Introduction
11.7.4 SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.7.5 SYSMED Recent Development
11.8 Fisher & Paykel
11.8.1 Fisher & Paykel Company Details
11.8.2 Fisher & Paykel Business Overview
11.8.3 Fisher & Paykel Ventilator Associated Pneumonia (VAP) Introduction
11.8.4 Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
11.8.5 Fisher & Paykel Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prevention
Table 3. Key Players of Physiotherapy
Table 4. Key Players of Immunity Therapy
Table 5. Global Ventilator Associated Pneumonia (VAP) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2016-2021)
Table 9. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2022-2027)
Table 11. Ventilator Associated Pneumonia (VAP) Market Trends
Table 12. Ventilator Associated Pneumonia (VAP) Market Drivers
Table 13. Ventilator Associated Pneumonia (VAP) Market Challenges
Table 14. Ventilator Associated Pneumonia (VAP) Market Restraints
Table 15. Global Ventilator Associated Pneumonia (VAP) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ventilator Associated Pneumonia (VAP) Market Share by Players (2016-2021)
Table 17. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2020)
Table 18. Ranking of Global Top Ventilator Associated Pneumonia (VAP) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ventilator Associated Pneumonia (VAP) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service
Table 22. Date of Enter into Ventilator Associated Pneumonia (VAP) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2016-2021)
Table 26. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ventilator Associated Pneumonia (VAP) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Application (2016-2021)
Table 30. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Philips Respironics Company Details
Table 63. Philips Respironics Business Overview
Table 64. Philips Respironics Ventilator Associated Pneumonia (VAP) Product
Table 65. Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 66. Philips Respironics Recent Development
Table 67. Hoffrichter Company Details
Table 68. Hoffrichter Business Overview
Table 69. Hoffrichter Ventilator Associated Pneumonia (VAP) Product
Table 70. Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 71. Hoffrichter Recent Development
Table 72. Johnson Controls Company Details
Table 73. Johnson Controls Business Overview
Table 74. Johnson Controls Ventilator Associated Pneumonia (VAP) Product
Table 75. Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 76. Johnson Controls Recent Development
Table 77. Teleflex Company Details
Table 78. Teleflex Business Overview
Table 79. Teleflex Ventilator Associated Pneumonia (VAP) Product
Table 80. Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 81. Teleflex Recent Development
Table 82. Weinmann Company Details
Table 83. Weinmann Business Overview
Table 84. Weinmann Ventilator Associated Pneumonia (VAP) Product
Table 85. Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 86. Weinmann Recent Development
Table 87. ResMed Company Details
Table 88. ResMed Business Overview
Table 89. ResMed Ventilator Associated Pneumonia (VAP) Product
Table 90. ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 91. ResMed Recent Development
Table 92. SYSMED Company Details
Table 93. SYSMED Business Overview
Table 94. SYSMED Ventilator Associated Pneumonia (VAP) Product
Table 95. SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 96. SYSMED Recent Development
Table 97. Fisher & Paykel Company Details
Table 98. Fisher & Paykel Business Overview
Table 99. Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million)
Table 100. Fisher & Paykel Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ventilator Associated Pneumonia (VAP) Market Share by Type: 2020 VS 2027
Figure 2. Prevention Features
Figure 3. Physiotherapy Features
Figure 4. Immunity Therapy Features
Figure 5. Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. ASCs Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Ventilator Associated Pneumonia (VAP) Report Years Considered
Figure 10. Global Ventilator Associated Pneumonia (VAP) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Ventilator Associated Pneumonia (VAP) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions: 2020 VS 2027
Figure 13. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2022-2027)
Figure 14. Global Ventilator Associated Pneumonia (VAP) Market Share by Players in 2020
Figure 15. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Ventilator Associated Pneumonia (VAP) Revenue in 2020
Figure 17. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2016-2021)
Figure 18. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2022-2027)
Figure 19. North America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027)
Figure 21. North America Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027)
Figure 22. North America Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027)
Figure 23. United States Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027)
Figure 27. Europe Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027)
Figure 28. Europe Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027)
Figure 29. Germany Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Region (2016-2027)
Figure 39. China Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027)
Figure 47. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027)
Figure 48. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027)
Figure 49. Mexico Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027)
Figure 55. Turkey Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Philips Respironics Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 59. Hoffrichter Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 60. Johnson Controls Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 61. Teleflex Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 62. Weinmann Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 63. ResMed Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 64. SYSMED Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 65. Fisher & Paykel Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---